Overview

Intrauterine G-CSF Administration in RIF

Status:
Completed
Trial end date:
2018-12-20
Target enrollment:
0
Participant gender:
Female
Summary
Aim of this study is to investigate the effects of intrauterine G-CSF on endometrial thickness, clinical pregnancy rate and live birth rate in a recurrent implantation failure (RIF) group
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Gurgan Clinic
Treatments:
Lenograstim
Criteria
Inclusion Criteria:

- Women under the age of 40 who met the RIF definition

- Follicle-stimulating hormone (FSH) levels were <15 IU/mL

Exclusion Criteria:

- Patients with congenital uterine anomalies

- Patients with Asherman's syndrome

- Patients with uterine cavity distorted by myoma or endometrial polyps

- Patients with confirmed endometriosis or endometrioma

- Patients for whom G-CSF was contraindicated (active infections, kidney disease, sickle
cell anemia, malignancies, chronic neutropenia)